Explaining the high rate of progression from prediabetes to type 2 diabetes in China - Authors' reply
Lancet Diabetes Endocrinol
.
2023 Nov;11(11):794-795.
doi: 10.1016/S2213-8587(23)00283-8.
Authors
Lihui Zhang
1
,
Qiuhong Gong
2
,
Ningling Sun
3
,
Linong Ji
4
,
Guangwei Li
5
Affiliations
1
The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
2
Department of Endocrinology, Fuwai Hospital and Chinese Academy of Medical Sciences, Beijing 100037, China.
3
Department of Hypertension, Peking University People's Hospital, Beijing, China.
4
Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, China.
5
Department of Endocrinology, Fuwai Hospital and Chinese Academy of Medical Sciences, Beijing 100037, China. Electronic address:
[email protected]
.
PMID:
37884323
DOI:
10.1016/S2213-8587(23)00283-8
No abstract available
Publication types
Letter
Comment
MeSH terms
Blood Glucose
China / epidemiology
Diabetes Mellitus, Type 2* / epidemiology
Humans
Prediabetic State* / epidemiology
Risk Factors
Substances
Blood Glucose